Andrea Necchi: All you need to know about TAR-200

Andrea Necchi, Associate Editor of the Journal of Clinical Oncology, shared on LinkedIn:

“All you need to know about TAR-200

Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer – ScienceDirect

Authors: Siamak Daneshmand D., Ashish M. Kamat, Neal D. Shore, Joshua J. Meeks, Matthew D. Galsky, Joseph M. Jacob, Michiel S. van der Heijden, Stephen B. Williams, Thomas Powles, Sam S. Chang, James W.F. Catto, Sarah P. Psutka, Félix Guerrero-Ramos, Evanguelos Xylinas, Makito Miyake, Giuseppe Simone, Karen Daniel, Hussein Sweiti, Christopher Cutie, Andrea Necchi.”

Blog Posts

Andrea Necchi Ashish M. Kamat cancer Christopher Cutie Evanguelos Xylinas Félix Guerrero-Ramos Giuseppe Simone Hussein Sweiti James W.F. Catto Joseph M. Jacob Joshua J. Meeks Karen Daniel Makito Miyake Matthew D. Galsky Michiel S. Van der Heijden Neal D. Shore OncoDaily Oncology Sam S. Chang Sarah P. Psutka Siamak Daneshmand D. Stephen B. Williams Thomas Powles